chloroquine has been researched along with B-Cell Leukemia in 2 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahoney, E | 1 |
| Maddocks, K | 1 |
| Flynn, J | 1 |
| Jones, J | 1 |
| Cole, SL | 1 |
| Zhang, X | 1 |
| Byrd, JC | 1 |
| Johnson, AJ | 1 |
| Vervoordeldonk, SF | 1 |
| Balkenende, AY | 1 |
| van den Berg, H | 1 |
| von dem Borne, AE | 1 |
| van der Schoot, CE | 1 |
| Van Leeuwen, EF | 1 |
| Slaper-Cortenbach, IC | 1 |
2 other studies available for chloroquine and B-Cell Leukemia
| Article | Year |
|---|---|
Identification of endoplasmic reticulum stress-inducing agents by antagonizing autophagy: a new potential strategy for identification of anti-cancer therapeutics in B-cell malignancies.
Topics: Antineoplastic Agents; Autophagy; Biomarkers; Cells, Cultured; Chloroquine; Endoplasmic Reticulum St | 2013 |
Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCgamma-receptor-II-mediated mechanism and by drugs.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymphocy | 1996 |